🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.03
-0.16 (-2.23%)
Nov 20, 2026, 11:37 AM EST - Market open

MRVI Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
73.02216.89322.4574.96632.14551.27
Trading Asset Securities
--1.38---
Cash & Short-Term Investments
73.02216.89323.77574.96632.14551.27
Cash Growth
-70.02%-33.01%-43.69%-9.04%14.67%133.41%
Accounts Receivable
25.7125.538.5254.61138.62117.51
Other Receivables
---1.18.19-
Receivables
25.7125.538.5255.71146.81117.51
Inventory
43.2540.550.0851.443.1551.56
Prepaid Expenses
11.5313.3716.7717.8525.819.7
Total Current Assets
154296.25429.15699.91847.9740.04
Property, Plant & Equipment
183.93190.74217.03222.65116.5995.43
Long-Term Investments
---8.5611.360.54
Goodwill
129.43129.43159.88326.03283.67152.77
Other Intangible Assets
130.97151.54194.96220.99216.66117.57
Long-Term Deferred Tax Assets
----765.8808.12
Long-Term Deferred Charges
3.4-----
Other Long-Term Assets
-1.662.627.249.3240.333.82
Total Assets
600.07770.581,0081,4872,2821,918

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6.482.9111.9610.735.998.15
Accrued Expenses
18.3322.628.0229.0435.4428.32
Current Portion of Long-Term Debt
1.55.445.445.445.446
Current Portion of Leases
1.388.768.277.416.273.72
Current Income Taxes Payable
-----0.1
Current Unearned Revenue
4.82.993.295.524.7512.64
Other Current Liabilities
0.572.22-29.3352.2534.84
Total Current Liabilities
33.0644.9256.9787.47110.1493.78
Long-Term Debt
145.68286.33290.49518.71522524.59
Long-Term Leases
77.3464.1872.4979.4151.5640.91
Long-Term Deferred Tax Liabilities
-2.250.01---
Other Long-Term Liabilities
3.820.211.0711.98693.38713.64
Total Liabilities
259.9397.87431.04697.571,3771,373

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2.62.562.532.512.552.55
Additional Paid-In Capital
212.7199.18181.87128.5137.9128.39
Retained Earnings
-19.8710.12140.89285.74404.77184.56
Comprehensive Income & Other
0.460.52----
Total Common Equity
195.89212.38325.29416.75545.22315.5
Minority Interest
144.28160.33251.92373.13360.03229.86
Shareholders' Equity
340.17372.71577.21789.88905.24545.36
Total Liabilities & Equity
600.07770.581,0081,4872,2821,918

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
225.9364.71376.69610.97585.26575.22
Net Cash (Debt)
-152.87-147.82-52.92-36.0146.88-23.95
Net Cash Growth
------
Net Cash Per Share
-1.04-1.02-0.38-0.270.18-0.09
Filing Date Shares Outstanding
149.25146.38143.65132.31131.79131.49
Total Common Shares Outstanding
149.2145.32141.98132.23131.69131.49
Working Capital
120.94251.33372.18612.44737.76646.26
Book Value Per Share
1.311.462.293.154.142.40
Tangible Book Value
-64.51-68.59-29.54-130.2644.8945.16
Tangible Book Value Per Share
-0.43-0.47-0.21-0.990.340.34
Machinery
-82.0673.3648.7935.9131.07
Construction In Progress
-14.6823.7639.6413.196.92
Leasehold Improvements
-39.2537.5924.8720.118.16
SEC Filings: 10-K · 10-Q